Cookie Consent by Free Privacy Policy website Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external defibrillators
giugno 23, 2020 - Philips

Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external defibrillators

Comunicato Stampa disponibile solo in lingua originale. 

Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in #health technology, today announced that the Center for Devices and Radiological #health (CDRH) of the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for the company’s HeartStart FR3 [1] and HeartStart FRx [2] automated external defibrillators (AEDs), and their supporting accessories, including batteries and pads.

The HeartStart FR3 is a professional grade AED with advanced features to help medical personnel and first-responders treat cardiac arrest. The HeartStart FRx is a public-access AED that features intuitive, step-by-step voice instructions, including cardiopulmonary resuscitation (CPR) guidance, for emergency use in workplaces, schools and other public spaces, as well as for medical professional use. 

“We are pleased to receive premarket approval for our HeartStart FR3 and HeartStart FRx AEDs,” said Arman Voskerchyan, Business Leader Therapeutic Care at #philips. “This complements the premarket approval that we received last year for our HeartStart OnSite and HeartStart Home AEDs. Our industry leading portfolio of AEDs is instrumental in helping save the lives of numerous sudden cardiac arrest victims in the U.S. and worldwide. We look forward to continuing to meet our commitment to our medical professional and public-access customers, and especially to the victims of sudden cardiac arrest who rely on our AEDs.”

FDA PMA information for the HeartStart FR3 and HeartStart FRx defibrillators can be found here and here, respectively. These devices have been marketed to date under FDA premarket notifications (510(k)), but are now approved under PMA.

In 2019, #philips received PMA approval for its HeartStart OnSite and HeartStart Home defibrillators, which are the only over-the-counter AEDs available to consumers in the U.S. 

[1] Model 861388 and Model 861389

[2] Model 861304

Ti potrebbe interessare anche

ottobre 13, 2023
ottobre 10, 2023
giugno 15, 2023

Comunicato Stampa disponibile solo in lingua originale. Animations, colors, and shapes help to improve poor situational awareness,...

Comunicato Stampa disponibile solo in lingua originale. Two-year #partnership focused on advocacy, education, and raising awarenes...

Comunicato Stampa disponibile solo in lingua originale. The Innovative #health Initiative has awarded a EUR 24 million grant to th...